Somnee Overview

  • Founded
  • 2017

Founded
  • Status
  • Private

  • Employees
  • 17

Employees
  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $8.3M

  • Investors
  • 3

Somnee General Information

Description

Developer of a brain stimulation system intended to improve sleep quality and efficiency. The company's system uses multi-modal brain stimulation that is personalized for individuals to provide efficacious enhancements to sleep, enabling customers to improve memory and cognitive performance.

Contact Information

Formerly Known As
StimScience
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 2115 Milvia Street
  • Suite 400
  • Berkeley, CA 94704
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Somnee Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 05-Apr-2021 $8.3M 00.00 000.00 Completed Product In Beta Test
To view Somnee’s complete valuation and funding history, request access »

Somnee Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2B 00,000,000 00 00.00 00.00 00 00.00 00.000
Seed 2A 00,000,000 00 00.00 00.00 00 00.00 00.000
Seed-1 18,331,805 8% $0.11 $0.11 1x $0.11 8.28%
To view Somnee’s complete cap table history, request access »

Somnee Patents

Somnee Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3957246-A1 Systems and devices for measurement, identification and generation of sleep state models Pending 21-Aug-2020 000000000 0
US-20220054793-A1 Systems, methods, and devices for measurement, identification, and generation of sleep state models Pending 21-Aug-2020 000000000
EP-3957248-A1 Systems, methods and devices for biomarker shaping and sleep profile enhancement Pending 21-Aug-2020 000000000
US-20220054794-A1 Systems, methods, and devices for biomarker shaping and sleep profile enhancement Pending 21-Aug-2020 000000000 0
US-20220059208-A1 Systems, methods, and devices for sleep intervention quality estimation Pending 21-Aug-2020 G16H50/20
To view Somnee’s complete patent history, request access »

Somnee Executive Team (4)

Name Title Board Seat Contact Info
Aaron Bromberg Chief Executive Officer & Board Member
Ram Gurumoorthy Co-Founder, Chief Technology Officer & Board Member
A. Pradeep Ph.D Co-Founder
You’re viewing 3 of 4 executive team members. Get the full list »

Somnee Board Members (3)

Name Representing Role Since
Aaron Bromberg Somnee Chief Executive Officer & Board Member 000 0000
Alexander Morgan Ph.D Self Board Member 000 0000
Ram Gurumoorthy Somnee Co-Founder, Chief Technology Officer & Board Member 000 0000
To view Somnee’s complete board members history, request access »

Somnee Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Somnee Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Great Eagle Holdings Real Estate Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
Monozukuri Ventures Venture Capital Minority 000 0000 000000 0
To view Somnee’s complete investors history, request access »